Evidence map›Paper›PMID 34599856›Full record

ArticleJournal of applied clinical medical physics2021

Dosimetric impact of simulated changes in large bowel content during proton therapy with simultaneous integrated boost for locally advanced pancreatic cancer.

Yuki Narita, Takahiro Kato, Kimihiro Takemasa, Hiroki Sato, Tomohiro Ikeda, Takaomi Harada, Sho Oyama, Masao Murakami

Open access · goldAbstract read
In one paragraph

Article in Journal of applied clinical medical physics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yuki NaritaDepartment of Radiation Physics and Technology, Southern Tohoku Proton Therapy Center, Fukushima, Japan.ORCID https://orcid.org/0000-0001-7594-6376
Takahiro KatoDepartment of Radiation Physics and Technology, Southern Tohoku Proton Therapy Center, Fukushima, Japan.
Kimihiro TakemasaDepartment of Radiation Physics and Technology, Southern Tohoku Proton Therapy Center, Fukushima, Japan.
Hiroki SatoDepartment of Radiation Physics and Technology, Southern Tohoku Proton Therapy Center, Fukushima, Japan.
Tomohiro IkedaDepartment of Radiation Physics and Technology, Southern Tohoku Proton Therapy Center, Fukushima, Japan.
Takaomi HaradaDepartment of Radiation Physics and Technology, Southern Tohoku Proton Therapy Center, Fukushima, Japan.
Sho OyamaDepartment of Radiation Physics and Technology, Southern Tohoku Proton Therapy Center, Fukushima, Japan.
Masao MurakamiDepartment of Radiation Oncology, Southern Tohoku Proton Therapy Center, Fukushima, Japan.
Southern Tohoku General Hospital · JPFukushima Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo investigate the dosimetric impact of changes in the large bowel content during proton therapy (PT) with simultaneous integrated boost (SIB) for locally advanced pancreatic cancer (LAPC). MATERIALS AND

methodsFifteen patients with LAPC were included in this study. The SIB method was performed using five fields according to our standard protocol. A total dose of 67.5 Gy(relative biological effectiveness [RBE]) was prescribed in 25 fractions using the SIB method. A dose of 45 Gy(RBE) was prescribed for the entire planning target volume (PTV) by using four main fields. The remaining 22.5 Gy(RBE) was prescribed to the PTV excluding for the gastrointestinal tract using one subfield. Five simulated doses were obtained by the forward dose calculations with the Hounsfield units (HU) override to the large bowel to 50, 0, -100, -500, and -1000, respectively. The dose-volume indices in each plan were compared using the 50 HU plan as a reference.

resultsAt D

conclusionDensity change in the large bowel was revealed to significantly affect the doses of the CTV and spinal cord during PT with SIB for LAPC. For beam arrangement, it is important to select a gantry angle that prevents the large bowel from passing as much as possible. If this is unavoidable, it is important to carefully observe the gas image on the beam path during daily image guidance and to provide adaptive re-planning as needed.

Indexed as

Pancreatic NeoplasmsProton TherapyRadiotherapy, Intensity-ModulatedHumansOrgans at RiskRadiotherapy DosageRadiotherapy Planning, Computer-Assistedgastrointestinal tractpancreatic cancerproton therapysimultaneous integrated boost

Identifiers

PMID34599856
PMCPMC8598140
OpenAlexW3204276079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.